Category Health/Medical

Resveratrol Stabilizes Alzheimer’s Biomarker that Decreases with Progression of disease

The largest nationwide clinical trial to study high-dose resveratrol long-term in people with mild to moderate Alzheimer’s disease found that a biomarker that declines when the disease progresses was stabilized in people who took the purified form of resveratrol. Resveratrol is a naturally occurring compound found in foods such as red grapes, raspberries, dark chocolate and some red wines.

The resveratrol clinical trial was a randomized, phase II, placebo-controlled, double blind study in 119 patients with mild to moderate dementia due to Alzheimer’s disease. An “investigational new drug” application was required by FDA to test the pure synthetic (pharmaceutical-grade) resveratrol in the study. It is not available commercially in this form...

Read More

Connection found between Fitness Level, Brain Activity, and Executive Function

Brain function associated with higher cardiorespiratory fitness plays a role in increased cognitive performance in older adults, according to a new study. Specifically, the scientists found that dual-task processing in a core executive function brain region is associated with higher cardiorespiratory fitness and dual-task performance.

With fMRI scans in the Beckman Institute’s Biomedical Imaging Center, the researchers found that certain regions of the brain were activated more when performing two simultaneous tasks compared to a single task.

“The reason we looked at dual-task specifically is because it’s a measure of executive function, which is required for multiple cognitive processes, such as working memory, task management, coordination, and 3inhibition,” said Wong...

Read More

An Antibody bNab that can Attack HIV in New Ways

Broadly neutralizing antibodies to HIV-1 envelope glycoprotein are being evaluated as therapeutics to prevent or treat HIV-1 infection. Structural analysis of one such antibody, 8ANC195, revealed a new conformation of the envelope protein. The image shows the X-ray crystal structure of 8ANC195 in complex with the gp120 subunit of the envelope protein. The background shows schematic representations of HIV-1 virus particles studded with envelope proteins being recognized by 8ANC195 antibodies. Credit: Louise Scharf/Caltech

Broadly neutralizing antibodies to HIV-1 envelope glycoprotein are being evaluated as therapeutics to prevent or treat HIV-1 infection. Structural analysis of one such antibody, 8ANC195, revealed a new conformation of the envelope protein. The image shows the X-ray crystal structure of 8ANC195 in complex with the gp120 subunit of the envelope protein. The background shows schematic representations of HIV-1 virus particles studded with envelope proteins being recognized by 8ANC195 antibodies. Credit: Louise Scharf/Caltech

Broadly neutralizing antibodies (bNAbs) are thought to be the future for treating and preventing HIV infections. A bNAb recently characterized by researchers can neutralize the virus in several different states – increasing the antibody’s promise as a therapeutic.

bNAbs ha...

Read More

Smart Immune Cells teach Neurons damaged by Parkinson’s to Heal themselves

Smart Immune Cells teach Neurons damaged by Parkinson's to Heal themselves

Smart Immune Cells teach Neurons damaged by Parkinson’s to Heal themselves

As a potential treatment for Parkinson’s disease, scientists have created smarter immune cells that produce and deliver a healing protein to the brain while also teaching neurons to begin making the protein for themselves.

The researchers, led by A/Prof Elena Batrakova at UNC Eshelman School of Pharmacy’s Center for Nanotechnology in Drug Delivery, genetically modified macrophages to produce glial cell-derived neurotrophic factor, or GDNF, and deliver it to the brain. Glial cells provide support and protection for nerve cells throughout the brain and body, and GDNF can heal and stimulate the growth of damaged neurons.

“Currently, there are no treatments that can halt or reverse the course of Parkinson’s disease...

Read More